CRISPR systems: Novel approaches for detection and combating COVID-19

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• Type V and VI CRISPR enzymes, specifically Cas12 and Cas13, are RNA-guided effectors capable of targeting DNA and RNA.
• Single-stranded RNA (ssRNA) viruses constitute a significant portion of human pathogens, necessitating advanced diagnostic and therapeutic solutions.
• The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic highlights the urgent need for rapid and accurate tools for disease management.

Purpose of the Study:

• To review the applications of Cas12 and Cas13 CRISPR systems in the diagnosis and treatment of RNA virus-mediated diseases.
• To discuss the pathogenicity of SARS-CoV-2 and current diagnostic and antiviral approaches.
• To highlight novel CRISPR-based diagnostic platforms and therapies for COVID-19 and address delivery challenges.

Main Methods:

• Review of existing literature on CRISPR-Cas12 and Cas13 systems.
• Analysis of SARS-CoV-2 characteristics, conventional diagnostics, and antivirals.
• Exploration of emerging CRISPR-based diagnostic and therapeutic strategies for COVID-19.

Main Results:

• CRISPR-Cas12 and Cas13 systems demonstrate significant potential for RNA virus detection and degradation.
• Novel CRISPR-based platforms offer enhanced accuracy and speed for SARS-CoV-2 diagnostics.
• CRISPR technology presents viable therapeutic avenues for RNA viral infections, including COVID-19.

Conclusions:

• CRISPR-based platforms represent a promising advancement for the accurate detection and treatment of SARS-CoV-2 and other RNA viral diseases.
• Addressing challenges in the in vivo delivery of CRISPR components is crucial for maximizing therapeutic efficacy.
• The programmability of CRISPR systems offers a versatile approach to combatting viral infections.